Moleculin Biotech
MBRX
MBRX
11 hedge funds and large institutions have $213K invested in Moleculin Biotech in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$57K | |
| 2 | +$46K | |
| 3 | +$41K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$41K |
| 5 |
Citigroup
New York
|
+$5.53K |
Top Sellers
| 1 | -$122K | |
| 2 | -$66K | |
| 3 | -$9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$833 |